AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England. Its R&D is concentrated in Cambridge, Gaithersburg, Maryland, and Mölndal in Sweden. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

0 shares	Share Tweet Save Post Send



Sanofi eyes vaccine approval by early 2021 French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports. Credit: Reuters Studio Duration: 01:13Published 3 weeks ago

AstraZeneca shares down after report it approached Gilead Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports Credit: Reuters Studio Duration: 01:09Published on June 8, 2020

AstraZeneca to make billion COVID vaccine doses if tests succeed AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage.. Credit: Reuters Studio Duration: 01:20Published on May 21, 2020

You Might Like

Corrupt Propositions: AstraZeneca and the Coronavirus Vaccine Drive Putting your destiny into the hands of a drug company is much like seeking reassurances from an opportunistic pimp. The returns are bound to mixed, dressed up in deceptive language. The promises,.. WorldNews - Published on June 14, 2020
AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help.. Reuters - Published on June 14, 2020Also reported by •Reuters India
AstraZeneca agrees to make Covid-19 vaccine for Europe Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing.. WorldNews - Published on June 13, 2020

Astrazeneca wins coronavirus vaccine deal with Germany, France, Italy and the Netherlands British drugmaker AstraZeneca Plc said on Saturday it signed a contract with Italy, Germany, France and the Netherlands to supply Europe with a vaccine against the coronavirus, with deliveries starting.. Reuters - Published on June 13, 2020
Italy, Germany, France and Netherlands sign contract with Astrazeneca for COVID vaccine Italy, Germany, France and the Netherlands have signed a contract with Astrazeneca to supply European citizens with a vaccine against the coronavirus, Italy's health minister said on Saturday. Reuters - Published on June 13, 2020
Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like.. Reuters India - Published on June 10, 2020

AstraZeneca contacted Gilead over potential megamerger: Bloomberg News Britain's AstraZeneca has approached U.S. rival Gilead Sciences about a possible merger to form one the world's largest drug companies, Bloomberg News reported on Sunday, citing people familiar with.. Reuters - Published on June 7, 2020
Coronavirus vaccine: AstraZeneca boosts potential supply to 2bn The drugs giant says it can double the production of a potential vaccine after backing by Bill Gates. BBC News - Published on June 5, 2020
India pledges $15 million to global vaccine alliance as AstraZeneca announces licensing deal with Serum Institute IndiaTimes - Published on June 4, 2020
Human trials of British coronavirus vaccine to reach 10,000 Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2.. Reuters - Published on May 22, 2020

$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine The Trump administration announced a grant to AstraZeneca, which has licensed a potential vaccine that is in trials by Oxford University. NYTimes.com - Published on May 21, 2020
US pledges up to $1.2 billion to access 300 million doses of experimental COVID-19 vaccine An experimental COVID-19 vaccine being developed at Oxford by AstraZeneca received a big order: $1.2 billion from the United States for 300 million doses. USATODAY.com - Published on May 21, 2020
AstraZeneca’s quest for Covid-19 vaccine gets $1bn boost from US London — UK pharmaceuticals group AstraZeneca says it has secured more than $1bn from the US to help fund production of its coronavirus vaccine. AstraZeneca is partnering with the University of.. WorldNews - Published on May 21, 2020	U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine The United States has secured almost a third of AstraZeneca's one billion possible COVID-19 vaccine doses by pledging up to $1.2 billion, as the world's biggest powers scramble for medicinal supplies.. Reuters - Published on May 21, 2020
U.S. commits $1.2 billion to possible British COVID vaccine The United States will pump up to $1.2 billion into developing AstraZeneca's potential COVID-19 vaccine and said on Thursday it would order 300 million doses, as the White House seeks solutions to the.. Reuters - Published on May 21, 2020	AstraZeneca to make billion COVID vaccine doses if tests succeed AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage.. Reuters - Published on May 21, 2020
AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators. Reuters - Published on January 27, 2020	AstraZeneca's combo lung disease therapy fails to win FDA approval The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday. Reuters - Published on October 1, 2019